After parental administration, P407 induces hypertriglyceridemia and hypercholesterolemia in rodents by inhibiting the heparin-releasable fraction of lipoprotein lipase (LPL) and the cholesterol 7α-hydroxylase (C7αH), respectively14, 15. Here, LPL is linked to hypertriglyceridemia.